← SynDRA
LOSARTAN
SynDRA canonical compound SYN0007815 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | AGTR1 |
| Mechanism of action | Angiotensin receptor antagonist |
| Indication | diabetic nephropathy | hypertension |
| Disease area | cardiology | nephrology |
All known targets
- AGTR1
- ABCB1
- GP6
- PDE4D
- PDE4C
- PDE4B
- PDE4A
- PDE3B
- PDE3A
- CYP2C9
- ABCG2
- Agtr2
Mechanisms of action (all sources)
- Angiotensin receptor antagonist
- AGTR1 ANTAGONIST
- Type-1 angiotensin II receptor antagonist
Drug classes
- Angiotensin 2 Receptor Antagonists
- Angiotensin 2 Receptor Blocker
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin Receptor Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
ATC classes
- C09C · ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
- ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
Cross-references
Synonyms
- allisartan
- lortaan
- losartan potassium
- losartan monopotassium
- losartan monopotassium salt
- Allisartan
- Angizaar
- Dup-89
- Exp-3174
- Losartan carboxylic acid
- Losartic
- Lozap
- E-3174
- EXP3174
- HGP-1405
- HGP1405
- NSC-758699
- EXP 3174
- UNII-GD76OCH73X
- CHEBI:74125
- CHEMBL907
- GD76OCH73X
- L-158641
- 2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
- 2-Butyl-4-chloro-1-[(2'-(1-H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl)methyl]-1-H-imidazole-5-carboxylic acid
- 1H-Imidazole-5-carboxylicacid, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- Carboxylic Acid Metabolite (E-3174)
- Cozaar
- Cozaar (TN)
- DUP 89
- DuP-753
- Hyzaar
- JMS50MPO89
- LOSARTAN POTASSIUM
- Lortaan
- Losartan (INN)
- C22H23ClN6O
- CHEBI:6541
Reported adverse events
- Cough
- Angioedema
- Hepatitis
- Hypotension
- Vasculitis
- Hypersensitivity
- Dysgeusia
- Rhabdomyolysis
- Thrombocytopenia
- Anaphylactic reaction
- Malaise
- Abdominal pain
Look up LOSARTAN in the interactive SynDRA portal →